Is Huntington's disease on the threshold of a new era in treatment?

Neurodegener Dis Manag. 2019 Oct;9(5):255-258. doi: 10.2217/nmt-2019-0015.
No abstract available

Keywords: Huntington's disease; antisense oligonucleotides; clinical trials.

Publication types

  • Editorial

MeSH terms

  • Animals
  • Clinical Trials as Topic
  • Humans
  • Huntingtin Protein / genetics
  • Huntington Disease / genetics*
  • Huntington Disease / therapy*
  • Oligonucleotides, Antisense / therapeutic use
  • Trinucleotide Repeats

Substances

  • HTT protein, human
  • Huntingtin Protein
  • Oligonucleotides, Antisense